Legal & General Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-65,156
| Closed | -$7.88M | – | 3438 |
|
|
2025
Q2 | $7.88M | Buy |
65,156
+14,073
| +28% | +$1.59M | ﹤0.01% | 1323 |
|
|
2025
Q1 | $5.69M | Buy |
51,083
+46,497
| +1,014% | +$4.95M | ﹤0.01% | 1462 |
|
|
2024
Q4 | $446K | Buy |
4,586
+339
| +8% | +$36.1K | ﹤0.01% | 2494 |
|
|
2024
Q3 | $488K | Buy |
4,247
+123
| +3% | +$14K | ﹤0.01% | 2467 |
|
|
2024
Q2 | $439K | Sell |
4,124
-832
| -17% | -$83.5K | ﹤0.01% | 2461 |
|
|
2024
Q1 | $479K | Buy |
+4,956
| New | +$508K | ﹤0.01% | 2444 |
|
|
2023
Q2 | – | Sell |
-194
| Closed | -$17.8K | – | 3480 |
|
|
2023
Q1 | $17.8K | Sell |
194
-17,275
| -99% | -$1.51M | ﹤0.01% | 3096 |
|
|
2022
Q4 | $1.58M | Buy |
17,469
+3,523
| +25% | +$297K | ﹤0.01% | 1977 |
|
|
2022
Q3 | $1.06M | Buy |
13,946
+1,247
| +10% | +$103K | ﹤0.01% | 2124 |
|
|
2022
Q2 | $1.07M | Sell |
12,699
-252
| -2% | -$22.1K | ﹤0.01% | 2140 |
|
|
2022
Q1 | $1.14M | Buy |
+12,951
| New | +$1.12M | ﹤0.01% | 2204 |
|
|
2015
Q4 | – | Sell |
-1,562
| Closed | -$129K | – | 2804 |
|
|
2015
Q3 | $129K | Hold |
1,562
| – | – | ﹤0.01% | 1901 |
|
|
2015
Q2 | $138K | Hold |
1,562
| – | – | ﹤0.01% | 1907 |
|
|
2015
Q1 | $138K | Hold |
1,562
| – | – | ﹤0.01% | 1844 |
|
|
2014
Q4 | $130K | Hold |
1,562
| – | – | ﹤0.01% | 1798 |
|
|
2014
Q3 | $132K | Hold |
1,562
| – | – | ﹤0.01% | 1720 |
|
|
2014
Q2 | $127K | Hold |
1,562
| – | – | ﹤0.01% | 1282 |
|
|
2014
Q1 | $119K | Hold |
1,562
| – | – | ﹤0.01% | 1258 |
|
|
2013
Q4 | $113K | Hold |
1,562
| – | – | ﹤0.01% | 1273 |
|
|
2013
Q3 | $107K | Sell |
1,562
-10,943
| -88% | -$724K | ﹤0.01% | 1264 |
|
|
2013
Q2 | $792K | Buy |
+12,505
| New | +$814K | ﹤0.01% | 932 |
|
Other funds holding NVS
